Monday, May 19, 2025 · SEC filings
What the smart money revealed on May 19
1,263 insider filings came in. We hid 92 planned (10b5-1) sellers and 963 people whose filings were routine, like grants and tax withholding.
3 insiders at Syndax Pharmaceuticals (SNDX) bought $242K of stock
Roles: CMO, Director. Several insiders buying in the same few days is rare.
3 insiders at Neonc Technologies (NTHI) bought $147K of stock
Roles: CEO, President, Director. Several insiders buying in the same few days is rare.
TXO Partners (TXO) Director Luther King Jr. bought $7.5M
500,000 shares on the open market. Not a grant or an option exercise.
Centessa Pharmaceuticals (CNTA) Director Arjun Goyal bought $5.87M
462,585 shares on the open market. Not a grant or an option exercise.
Patrick Industries (PATK) Director Todd Cleveland bought $952K
11,000 shares on the open market. Not a grant or an option exercise.
Globalstar (GSAT) Director James Monroe III bought $934K
50,000 shares on the open market. Not a grant or an option exercise.
Loar (LOAR) Director David Abrams sold $378M
Not marked as a planned 10b5-1 sale. Sold 12% of the shares they held directly. Still holds 32.75M shares.
Loar (LOAR) Director Anthony Carpenito sold $371M
Not marked as a planned 10b5-1 sale. Sold 12% of the shares they held directly. Still holds 32.13M shares.
AST SpaceMobile (ASTS) CTO Huiwen Yao sold $1.48M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 60 more real buys
Show 104 more real sales
13F season
Holdings as of Mar 31, 2025 were due May 15
92 funds have filed. 80 filed for the quarter before.
Biggest real insider buys, May 13–19
Open-market buys by officers and directors, filed in the 7 days up to May 19.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.